Paricalcitol for Secondary Hyperparathyroidism in Renal Transplantation

Secondary hyperparathyroidism contributes to post-transplant CKD mineral and bone disorder. Paricalcitol, a selective vitamin D receptor activator, decreased serum parathyroid hormone levels and proteinuria in patients with secondary hyperparathyroidism. This single-center, prospective, randomized,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Am Soc Nephrol
Main Authors: Trillini, Matias, Cortinovis, Monica, Ruggenenti, Piero, Reyes Loaeza, Jorge, Courville, Karen, Ferrer-Siles, Claudia, Prandini, Silvia, Gaspari, Flavio, Cannata, Antonio, Villa, Alessandro, Perna, Annalisa, Gotti, Eliana, Caruso, Maria Rosa, Martinetti, Davide, Remuzzi, Giuseppe, Perico, Norberto
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Nephrology 2015
Assuntos:
Clinical Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4413751/
https://ncbi.nlm.nih.gov/pubmed/25194004
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2013111185
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados